Beaumont Asset Management L.L.C. Sells 150 Shares of Albemarle Co. (NYSE:ALB)

Beaumont Asset Management L.L.C. decreased its position in Albemarle Co. (NYSE:ALB) by 4.6% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 3,125 shares of the specialty chemicals company’s stock after selling 150 shares during the quarter. Beaumont Asset Management L.L.C.’s holdings in Albemarle were worth $269,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds and other institutional investors have also bought and sold shares of ALB. Quarry LP lifted its holdings in shares of Albemarle by 1,400.0% in the 3rd quarter. Quarry LP now owns 270 shares of the specialty chemicals company’s stock worth $26,000 after acquiring an additional 252 shares during the last quarter. Trust Co. of Vermont lifted its stake in Albemarle by 606.5% in the fourth quarter. Trust Co. of Vermont now owns 325 shares of the specialty chemicals company’s stock worth $28,000 after purchasing an additional 279 shares during the last quarter. Eastern Bank purchased a new stake in Albemarle during the third quarter valued at about $31,000. Cromwell Holdings LLC grew its stake in shares of Albemarle by 61.9% during the third quarter. Cromwell Holdings LLC now owns 387 shares of the specialty chemicals company’s stock valued at $37,000 after buying an additional 148 shares during the last quarter. Finally, TD Private Client Wealth LLC increased its holdings in shares of Albemarle by 50.4% in the third quarter. TD Private Client Wealth LLC now owns 394 shares of the specialty chemicals company’s stock worth $37,000 after buying an additional 132 shares during the period. Hedge funds and other institutional investors own 92.87% of the company’s stock.

Albemarle Trading Down 2.2 %

NYSE:ALB opened at $77.30 on Friday. The company has a 50 day simple moving average of $91.91 and a two-hundred day simple moving average of $92.80. The company has a market cap of $9.09 billion, a PE ratio of -4.61, a price-to-earnings-growth ratio of 3.65 and a beta of 1.59. The company has a current ratio of 2.44, a quick ratio of 1.58 and a debt-to-equity ratio of 0.43. Albemarle Co. has a 12 month low of $71.97 and a 12 month high of $143.19.

Wall Street Analyst Weigh In

Several equities analysts recently issued reports on the company. Royal Bank of Canada raised their price target on Albemarle from $108.00 to $133.00 and gave the stock an “outperform” rating in a research report on Tuesday, November 12th. Evercore ISI downgraded shares of Albemarle from an “outperform” rating to an “inline” rating in a research note on Wednesday. Clarkson Capital started coverage on shares of Albemarle in a report on Tuesday, January 14th. They set a “buy” rating and a $112.00 price target for the company. KeyCorp cut their price target on shares of Albemarle from $132.00 to $127.00 and set an “overweight” rating on the stock in a report on Tuesday, November 12th. Finally, Truist Financial started coverage on shares of Albemarle in a research note on Tuesday, January 28th. They set a “hold” rating and a $96.00 price objective for the company. One analyst has rated the stock with a sell rating, fifteen have assigned a hold rating and six have assigned a buy rating to the stock. Based on data from MarketBeat.com, Albemarle presently has a consensus rating of “Hold” and a consensus target price of $113.95.

Insider Activity at Albemarle

In other Albemarle news, CEO J Kent Masters sold 2,525 shares of the business’s stock in a transaction dated Thursday, December 5th. The stock was sold at an average price of $101.12, for a total transaction of $255,328.00. Following the completion of the sale, the chief executive officer now directly owns 73,747 shares in the company, valued at $7,457,296.64. The trade was a 3.31 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. 0.38% of the stock is owned by company insiders.

Albemarle Profile

Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. It operates through three segments: Energy Storage, Specialties and Ketjen. The Energy Storage segment offers lithium compounds, including lithium carbonate, lithium hydroxide, and lithium chloride; technical services for the handling and use of reactive lithium products; and lithium-containing by-products recycling services.